ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
231.69
-1.10 (-0.47%)
Feb 21, 2025, 4:00 PM EST - Market closed

ResMed Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for ResMed stock have an average target of 250.67, with a low estimate of 180 and a high estimate of 286. The average target predicts an increase of 8.19% from the current stock price of 231.69.

Analyst Consensus: Buy
Target Low Average Median High
Price $180 $250.67 $260 $286
Change -22.31% +8.19% +12.22% +23.44%

Analyst Ratings

The average analyst rating for ResMed stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Sep '24Oct '24Nov '24Dec '24Jan '25Feb '25
Strong Buy 222222
Buy 444333
Hold 555666
Sell 111111
Strong Sell 000000
Total 121212121212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Maintains
$270$286
Buy Maintains $270$286 +23.44% Jan 31, 2025
Keybanc
Keybanc
Buy
Maintains
$266$280
Buy Maintains $266$280 +20.85% Jan 31, 2025
Piper Sandler
Piper Sandler
Hold
Maintains
$252$260
Hold Maintains $252$260 +12.22% Jan 31, 2025
Needham
Needham
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Jan 31, 2025
Piper Sandler
Piper Sandler
Hold
Initiates
$252
Hold Initiates $252 +8.77% Jan 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
5.16B
from 4.69B
Increased by 10.03%
Revenue Next Year
5.54B
from 5.16B
Increased by 7.37%
EPS This Year
9.54
from 6.92
Increased by 37.90%
EPS Next Year
10.52
from 9.54
Increased by 10.24%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Jun 30, 2020 Jun 30, 2021 Jun 30, 2022 Jun 30, 2023 Jun 30, 2024 Jun 30, 2025 Jun 30, 2026 Jun 30, 2027
Revenue
2.96B3.20B3.58B4.22B4.69B5.16B5.54B5.95B
Revenue Growth
13.44%8.11%11.93%18.02%10.95%10.03%7.37%7.48%
EPS
4.273.245.306.096.929.5410.5211.51
EPS Growth
52.50%-24.12%63.58%14.91%13.63%37.90%10.24%9.38%
Forward PE
-----24.2822.0320.14
No. Analysts -----191914
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 5.4B 5.9B 6.4B
Avg 5.2B 5.5B 5.9B
Low 5.0B 5.3B 5.6B

Revenue Growth

Revenue Growth 20252026202720282029
High
16.0%
13.5%
15.4%
Avg
10.0%
7.4%
7.5%
Low
5.8%
2.0%
1.5%

EPS Forecast

EPS 20252026202720282029
High 10.08 11.43 12.96
Avg 9.54 10.52 11.51
Low 9.10 9.92 10.56

EPS Growth

EPS Growth 20252026202720282029
High
45.7%
19.8%
23.2%
Avg
37.9%
10.2%
9.4%
Low
31.6%
3.9%
0.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.